Gizmodo reports recent company data pointing to measurable slowing of biological aging markers in people on GLP-1 drugs.
Recap by typeshit. Full story at Gizmodo.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
Lilly accuses the sellers of offering illicit versions of its experimental weight loss drug, as CEO Dave Ricks pushes regulators to step up enforcement.
A two-part roundup from Pharma Voice touching on the health department's research timelines and a set of odd side effects being reported on GLP-1 drugs.
Loading…